Patents Assigned to Ben-Gurion University of Negev, Research & Development Authority
  • Patent number: 8773895
    Abstract: A memory cell with an internal supply feedback loop is provided herein. The memory cell includes a latch having two storage nodes Q and QB, and a supply node. A gating device couples the supply node of the latch to the supply voltage. The gating device is controlled by a feedback loop coming from storage node QB. Due to the aforementioned asymmetric topology, the writing of logic “1” and the writing of logic “0” are carried out differently. Contrary to standard SRAM cells, in the hold states, only the QB storage node presents a valid value of stored data. The feedback loop cuts off the supply voltage for the latch such that the latch is no longer an inverting latch. By cutting off the supply voltage at the stable hold states, while maintaining readability of the memory cell, leakage currents associated with the hold states are eliminated altogether.
    Type: Grant
    Filed: February 26, 2013
    Date of Patent: July 8, 2014
    Assignee: Ben-Gurion University of the Negev Research and Development Authority
    Inventors: Adam Teman, Lidor Pergament, Omer Cohen, Alexander Fish
  • Publication number: 20140186837
    Abstract: Methods and kits for the detection of cancer and for pre-cancer screening based on the expression of genes associated with altered metabolism and apoptosis in cancerous cells, particularly the expression of a mitochondrial antiviral-signaling (MAVS) or a voltage-dependent anion channel 1 (VDAC1) protein or mRNA in combination with additional genes associated with cell metabolism and/or apoptosis.
    Type: Application
    Filed: March 7, 2014
    Publication date: July 3, 2014
    Applicants: THE NATIONAL INSTITUTE FOR BIOTECHNOLOGY IN THE NEGEV LTD., BEN-GURION UNIVERSITY OF THE NEGEV RESEARCH AND DEVELOPMENT AUTHORITY
    Inventor: Varda Shoshan-Barmatz
  • Patent number: 8750973
    Abstract: The invention provides an ECG system and apparatus for detecting P-waves even in the patients with arrhythmia. The system is capable of obtaining sufficient data from eight leads and to display an ECG construct with marked or emphasized P-waves.
    Type: Grant
    Filed: November 29, 2010
    Date of Patent: June 10, 2014
    Assignee: Ben-Gurion University of the Negev Research and Development Authority
    Inventors: Amos Katz, Nahum Noam Weissman, Yaniv Zigel
  • Patent number: 8743918
    Abstract: A device and a method enabling the enhancing of the modulation efficiency of lasers by matching the modulation frequency and the FSR of the laser. This is optionally achieved by eliminating the internal cavity of a laser diode (103) placed in an external cavity and matching the FSR of the external cavity to the modulation frequency. The modulation index is enhanced to and beyond the point of complete carrier suppression even at high modulation frequency and high beam intensities. The external cavity comprises a grating (107), the cavity length being adjusted with a PZT (108) and a translation stage (109). The laser diode (103) is driven by a bias current (110) from a driver (115) and a modulation current (111) from a modulation driver (116).
    Type: Grant
    Filed: September 24, 2009
    Date of Patent: June 3, 2014
    Assignee: Ben Gurion University of the Negev, Research and Development Authority
    Inventors: Menachem Givon, Amir Waxman
  • Patent number: 8735368
    Abstract: Antisense oligonucleotides against cPLA2 are provided, which are capable of inhibiting cPLA2 expression as well as superoxide production, especially in phagocytes. These antisense oligonucleotides are powerful agents for the treatment of inflammatory conditions, in particular arthritis, as well as in neurodegenerative diseases. The antisense oligonucleotides or compositions comprising the same may be used in methods of treatment of such diseases.
    Type: Grant
    Filed: July 12, 2012
    Date of Patent: May 27, 2014
    Assignees: Mor Research Applications Ltd., Ben-Gurion University of the Negev Research and Development Authority
    Inventor: Rachel Levy
  • Publication number: 20140142068
    Abstract: The present invention is directed to use of a series of compounds and compositions comprising the same for activating telomerase and treating diseases, disorders and/or conditions related thereto.
    Type: Application
    Filed: December 17, 2013
    Publication date: May 22, 2014
    Applicant: Ben-Gurion University of the Negev Research and Development Authority
    Inventors: Aviv GAZIT, Shimon SLAVIN, Esther PRIEL, Sara YITZCHAK
  • Publication number: 20140142067
    Abstract: The present invention is directed to use of a series of compounds and compositions comprising the same for activating telomerase and treating diseases, disorders and/or conditions related thereto.
    Type: Application
    Filed: November 12, 2013
    Publication date: May 22, 2014
    Applicant: BEN-GURION UNIVERSITY OF THE NEGEV RESEARCH AND DEVELOPMENT AUTHORITY
    Inventors: Aviv GAZIT, Shimon SLAVIN, Esther PRIEL, Sara YITZCHAK
  • Patent number: 8728533
    Abstract: Provided is a formulation containing amorphous or microcrystalline calcium carbonate finely interspersed with organic matter in a ratio of 10 parts of the carbonate per 1 to 3 parts of the organic matter, wherein the organic matter consists of chitin and polypeptide. The formulation is efficient in treating various pathological conditions, including proliferative diseases, neurological disorders, and musculoskeletal disorders.
    Type: Grant
    Filed: December 27, 2012
    Date of Patent: May 20, 2014
    Assignees: Ben-Gurion University of the Negev Research and Development Authority
    Inventors: Yossi Ben, Amir Sagi
  • Patent number: 8717678
    Abstract: The present invention provides an interferometer apparatus comprising a matter-wave guide enclosing an area, wherein a flux of particles may be guided in the matter-wave guide in at least two opposite paths, the matter-wave guide is rotatable relative to an inertial frame of reference; a first beam splitter to split the first beam to at least second and third beams, each of the second and third beams is to be guided in another path of the two opposite paths; and a second beam splitter allowing particles of the second and third beams to exit the matter-wave guide in a first probability and to stay in the matter-wave guide in a second probability.
    Type: Grant
    Filed: January 6, 2013
    Date of Patent: May 6, 2014
    Assignee: Ben Gurion University of the Negev, Research and Development Authority
    Inventors: Yonathan Japha, Ron Folman, Yshai Avishai
  • Patent number: 8716334
    Abstract: Novel substituted cyclohexylidene-ethylidene-octahydro-indene compounds and compositions comprising the same are described. The compounds exhibit profound anti-proliferative effects, in comparison to other compounds known for their anti-cancer and anti-hyperproliferative ability. Methods of use of such compounds and compositions are described for treating a variety of cancers, inflammatory and other hyperproliferative diseases and disorders.
    Type: Grant
    Filed: June 16, 2009
    Date of Patent: May 6, 2014
    Assignee: Ben Gurion University of the Negev Research and Development Authority
    Inventors: Shimon Ben Shabat, Amnou Sintov
  • Patent number: 8710109
    Abstract: There is provided herein a membrane or film comprising one or more aromatic ionomers covalently crosslinked through aryl-aryl (—Ar—Ar—), aryl-ether-aryl (—Ar—O—Ar—), aryl-sulfide-aryl (—Ar—S—Ar—), aryl-sulfone-aryl bonds, or any combination thereof, wherein said one or more aromatic ionomers further comprises at least one electron withdrawing group adapted to improve oxidant resistance of said membrane or film.
    Type: Grant
    Filed: February 21, 2010
    Date of Patent: April 29, 2014
    Assignee: Ben Gurion University of the Negev Research and Development Authority
    Inventors: Charles Linder, Ora Kedem, Yoram Oren
  • Publication number: 20140107336
    Abstract: The present invention relates to a novel class of tri-aryl compounds, compositions comprising the same and processes for the preparation thereof.
    Type: Application
    Filed: November 1, 2013
    Publication date: April 17, 2014
    Applicant: BEN-GURION UNIVERSITY OF THE NEGEV RESEARCH AND DEVELOPMENT AUTHORITY
    Inventors: Esther PRIEL, Aviv GAZIT, Shimon SLAVIN, Sara YITZCHAK
  • Patent number: 8691243
    Abstract: Vaccine compositions and methods for protecting a mammalian subject against infection with S. pneumoniae are disclosed. The vaccines and methods comprise an effective amount of one or more Streptococcus pneumoniae cell wall and/or cell membrane proteins and/or immunogenically-active fragments, derivatives or modifications thereof, wherein the proteins are selected from a defined group of proteins associated with age-dependent immunological responses.
    Type: Grant
    Filed: January 4, 2013
    Date of Patent: April 8, 2014
    Assignee: Ben-Gurion University of the Negev Research and Development Authority
    Inventor: Yaffa Mizrachi Nebenzahl
  • Patent number: 8658763
    Abstract: The present invention relates to the field of tissue engineering and more specifically to amphiphilic peptides and peptide matrices thereof useful in vitro and in situ biomineralization and inducing bone repair. The present invention provides peptides, which are useful in hydrogels and other pharmaceutical compositions, and methods and kits of use for bone repair and promotion of biomineralization. Certain hydrogels according to the invention comprise cells within or adhered to the peptide matrix.
    Type: Grant
    Filed: June 19, 2007
    Date of Patent: February 25, 2014
    Assignee: Ben-Gurion University of the Negev Research and Development Authority
    Inventor: Hanna Rapaport
  • Patent number: 8648045
    Abstract: The present invention relates generally to the mitochondrial protein, voltage-dependent anion channel (VDAC), polynucleotides encoding same and variants thereof, as well as peptide fragments, peptide derivatives and analogs. In particular, the present invention is directed to VDAC1 and specific amino acid and polynucleotide sequences thereof useful in inducing or regulating apoptosis and to pharmaceutical compositions comprising same useful in the treatment of diseases associated with aberrant apoptosis.
    Type: Grant
    Filed: February 15, 2012
    Date of Patent: February 11, 2014
    Assignee: Ben Gurion University of the Negev Research and Development Authority Ltd.
    Inventors: Varda Shoshan-Barmatz, Salah Abu-Hamad, Laetitia Arzoine, Hilal Zaid
  • Patent number: 8647635
    Abstract: Provided is a composition which contains a red microalga polysaccharide and a heavy metal, which is used as a cosmetic, diagnostic, or pharmaceutical formulation. The pharmaceutical formulation may be employed topically or for treating nutritional and other disorders.
    Type: Grant
    Filed: May 21, 2009
    Date of Patent: February 11, 2014
    Assignee: Ben-Gurion University of the Negev Research and Development Authority
    Inventor: Shosh Arad
  • Publication number: 20140026664
    Abstract: Apparatus for detection of human falls comprises: an acceleration detector, for detecting vibration events, typically placed on a floor, a microphone, located in association with the acceleration detector for detection of corresponding sound events, and a classification unit to classify concurrent events from the microphone and the acceleration detector, thereby to determine whether a human fall is indicated. If the event appears to be a human fall, then an alarm is raised.
    Type: Application
    Filed: September 30, 2013
    Publication date: January 30, 2014
    Applicants: Ben-Gurion University of the Negev Research and Development Authority, Ramot at Tel-Aviv University Ltd.
    Inventors: Israel GANNOT, Dimitry LITVAK, Yaniv ZIGEL
  • Patent number: 8639947
    Abstract: A database encryption system and method, the Structure Preserving Database Encryption (SPDE), is presented. In the SPDE method, each database cell is encrypted with its unique position. The SPDE method permits to convert a conventional database index into a secure one, so that the time complexity of all queries is maintained. No one with access to the encrypted database can learn anything about its content without the encryption key. Also a secure index for an encrypted database is provided. Furthermore, secure database indexing system and method are described, providing protection against information leakage and unauthorized modifications by using encryption, dummy values and pooling, and supporting discretionary access control in a multi-user environment.
    Type: Grant
    Filed: May 30, 2005
    Date of Patent: January 28, 2014
    Assignee: Ben Gurion University of the Negev Research and Development Authority
    Inventors: Yuval Elovici, Ronen Waisenberg, Erez Shmueli
  • Patent number: 8632682
    Abstract: A method for operating a tapered flow pressure driven arrangement containing a plurality of membrane modules, which comprises positioning said membrane modules in at least two successively arranged flow stages, such that the number of membrane modules operating in parallel in a given flow stage is greater than their number in the consecutive flow stage, passing a feed stream through a flow stage to generate a permeate and a concentrate, directing said concentrate to the consecutive flow stage and passing said concentrate therethrough, while periodically replacing one or more of the membrane modules belonging to said consecutive flow stage with one or more membrane modules belonging to the previous flow stage, wherein the periodicity of said replacement is such that the surface of membranes disposed in said consecutive flow stage is exposed to super-saturation conditions associated with the passage of said concentrate for a period of time that is shorter than the time required for said concentrate to precipita
    Type: Grant
    Filed: June 22, 2006
    Date of Patent: January 21, 2014
    Assignee: Ben-Gurion University of the Negev Research and Development Authority
    Inventor: Jack L. Gilron
  • Patent number: 8609736
    Abstract: The present invention is directed to use of a series of compounds and compositions comprising the same for activating telomerase and treating diseases, disorders and/or conditions related thereto.
    Type: Grant
    Filed: June 4, 2008
    Date of Patent: December 17, 2013
    Assignee: Ben-Gurion University of the Negev Research and Development Authority
    Inventors: Aviv Gazit, Shimon Slavin, Esther Priel, Sara Yitzchak